Uncategorized – Satellos

SATELLOS INC. Announces Licensing of Formulation Technology and Expand Collaboration with NW PHARMATECH LTD.

TORONTO, October 6, 2022 – Satellos Bioscience Inc. (TSXV: MSCL) (“Satellos” or the “Corporation”), is

Jessica Richmond2022-10-06T21:53:11+00:00October 6th, 2022|2022, Press Releases, Uncategorized|

SATELLOS BIOSCIENCE ANNOUNCES OTCQB LISTING IN THE UNITED STATES TORONTO, October 6, 2022 – Satellos

Jessica Richmond2022-10-11T21:37:12+00:00October 6th, 2022|2022, Press Releases, Uncategorized|

NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES OR FOR DISSEMINATION TO U.S. NEWS

Jessica Richmond2022-09-09T12:55:32+00:00September 7th, 2022|2022, Press Releases, Uncategorized|

SATELLOS BIOSCIENCE INC. TO PRESENT GAME CHANGING SCIENCE AT UPCOMING EUROPEAN MOLECULAR BIOLOGY ORGANIZATION WORKSHOP Ryan